PowerPoint Presentation

Targeted therapies in non-melanoma skin cancer

BCC

SCC

Substance

Vismodegib

Cetuximab

Targeted molecules

Inhibitor of smoothened Inhibitor of EGFR

Remarks

FDA-approved for

FDA-approved for

advanced and

head and neck SCC

metastatic BCC

together with

radiotherapy